What Is the Optimal Blood Pressure in Patients After Acute Coronary Syndromes? Relationship of Blood Pressure and Cardiovascular Events in the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction (PROVE IT-TIMI) 22 Trial

被引:177
作者
Bangalore, Sripal [2 ]
Qin, Jie
Sloan, Sarah
Murphy, Sabina A.
Cannon, Christopher P. [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, TIMI Study Grp,Div Cardiovasc Med, Boston, MA 02115 USA
[2] NYU, Sch Med, New York, NY USA
关键词
blood pressure; hypertension; prognosis; acute coronary syndrome; J-CURVE; HYPERTENSIVE PATIENTS; HEART-DISEASE; REDUCTION; DEATH; PREVENTION; MANAGEMENT; MORTALITY; POINT; RISK;
D O I
10.1161/CIRCULATIONAHA.109.905687
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Aggressive blood pressure (BP) control has been advocated in patients with acute coronary syndrome, but few data exist in this population relative to cardiovascular outcomes. Methods and Results-We evaluated 4162 patients enrolled in the PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial (acute coronary syndrome patients randomized to pravastatin 40 mg versus atorvastatin 80 mg). The average follow-up BP (systolic and diastolic) was categorized into 10-mm Hg increments. The primary outcome was a composite of death due to any cause, myocardial infarction, unstable angina requiring rehospitalization, revascularization after 30 days, and stroke. The secondary outcome was a composite of death due to coronary heart disease, nonfatal myocardial infarction, or revascularization. The relationship between BP (systolic or diastolic) followed a J- or U-shaped curve association with primary, secondary, and individual outcomes, with increased events rates at both low and high BP values, both unadjusted and after adjustment for baseline variables, baseline C-reactive protein, and on-treatment average levels of low-density lipoprotein cholesterol. A nonlinear Cox proportional hazards model showed a nadir of 136/85 mm Hg (range 130 to 140 mm Hg systolic and 80 to 90 mm Hg diastolic) at which the incidence of primary outcome was lowest. The curve was relatively flat for systolic pressures of 110 to 130 mm Hg and diastolic pressures of 70 to 90 mm Hg. Conclusions-After acute coronary syndrome, a J- or U-shaped curve association existed between BP and the risk of future cardiovascular events, with lowest event rates in the BP range of approximately 130 to 140 mm Hg systolic and 80 to 90 mm Hg diastolic and a relatively flat curve for systolic pressures of 110 to 130 mm Hg and diastolic pressures of 70 to 90 mm Hg, which suggests that too low of a pressure (especially <110/70 mm Hg) may be dangerous.
引用
收藏
页码:2142 / 2151
页数:10
相关论文
共 30 条
  • [1] 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
    Afridi, I
    Canny, J
    Yao, CH
    Christensen, B
    Cooper, RS
    Kadiri, S
    Hill, S
    Kaplan, N
    Kuschnir, E
    Lexchin, J
    Mendis, S
    Poulter, N
    Psaty, BM
    Rahn, KH
    Sheps, SG
    Whitworth, J
    Yach, D
    Bengoa, R
    Ramsay, L
    Kaplan, N
    Mendis, S
    Poulter, N
    Whitworth, J
    [J]. JOURNAL OF HYPERTENSION, 2003, 21 (11) : 1983 - 1992
  • [2] ANDERSON TW, 1978, LANCET, V2, P1139
  • [3] [Anonymous], 1985, J Hypertens, V3, P379
  • [4] [Anonymous], 1982, Lancet, V1, P185
  • [5] [Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI [10.1001/archinte.157.21.2413, DOI 10.1001/ARCHINTE.157.21.2413]
  • [6] Treatment blood pressure targets for hypertension (Review)
    Arguedas, Jose Agustin
    Perez, Marco I.
    Wright, James M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (03):
  • [7] Design of the Pravastatin or Atorvastation Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial
    Cannon, CP
    McCabe, CH
    Belder, R
    Breen, J
    Braunwald, E
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (07) : 860 - +
  • [8] Intensive versus moderate lipid lowering with statins after acute coronary syndromes
    Cannon, CP
    Braunwald, E
    McCabe, CH
    Rader, DJ
    Rouleau, JL
    Belder, R
    Joyal, SV
    Hill, KA
    Pfeffer, MA
    Skene, AM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (15) : 1495 - 1504
  • [9] Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    Chobanian, AV
    Bakris, GL
    Black, HR
    Cushman, WC
    Green, LA
    Izzo, JL
    Jones, DW
    Materson, BJ
    Oparil, S
    Wright, JT
    Roccella, EJ
    [J]. HYPERTENSION, 2003, 42 (06) : 1206 - 1252
  • [10] Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease
    Cooper-DeHoff, Rhonda M.
    Gong, Yan
    Handberg, Eileen M.
    Bavry, Anthony A.
    Denardo, Scott J.
    Bakris, George L.
    Pepine, Carl J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (01): : 61 - 68